Page last updated: 2024-08-21

glycyrrhizic acid and Autoimmune Chronic Hepatitis

glycyrrhizic acid has been researched along with Autoimmune Chronic Hepatitis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Aithal, GP; Bi, JF; Chang, BX; Huang, A; Ji, D; Liang, QS; Liangpunsakul, S; Liu, S; Ma, X; Mao, YM; Niu, M; Peng, XX; Saxena, R; Sun, Y; Teng, GJ; Tian, H; Wang, JB; Wang, Y; Xiao, XH; Xie, H; Xin, S; Zhao, J; Zhou, G; Zou, Z1
Bi, X; Deng, W; Jiang, T; Li, M; Lin, Y; Lu, Y; Xie, Y; Yang, L; Yi, W; Zhang, L1
Gao, M; He, L; Li, X; Wei, H; Xiao, F; Yang, J; Ye, X1
Xia, LX; Xiao, T1
Fujiwara, K; Fukuda, Y; Nakano, M; Tawada, A; Yasui, S; Yokosuka, O1
Hayashi, A; Hoshino, S; Ohkoshi, N; Shoji, S; Tamaoka, A; Yoshizawa, T1

Trials

1 trial(s) available for glycyrrhizic acid and Autoimmune Chronic Hepatitis

ArticleYear
Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial.
    Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:10

    Topics: Adrenal Cortex Hormones; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Female; Glycyrrhizic Acid; Hepatitis, Autoimmune; Humans; Male

2022

Other Studies

5 other study(ies) available for glycyrrhizic acid and Autoimmune Chronic Hepatitis

ArticleYear
Efficacy and Safety of Glycyrrhizic Acid in Treatment of Autoimmune Hepatitis.
    The American journal of Chinese medicine, 2023, Volume: 51, Issue:2

    Topics: Glycyrrhizic Acid; Hepatitis, Autoimmune; Humans; Treatment Outcome

2023
Diammonium Glycyrrhizinate Mitigates Liver Injury Via Inhibiting Proliferation Of NKT Cells And Promoting Proliferation Of Tregs.
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Animals; Anti-Inflammatory Agents; Cell Proliferation; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Dose-Response Relationship, Drug; Glycyrrhizic Acid; Hepatitis, Autoimmune; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Natural Killer T-Cells; Structure-Activity Relationship; T-Lymphocytes, Regulatory

2019
An unusual case of autoimmune hepatitis in a patient with adult-onset Still's disease.
    Clinical rheumatology, 2010, Volume: 29, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Glycyrrhizic Acid; Hepatitis, Autoimmune; Humans; Methylprednisolone; Still's Disease, Adult-Onset; Treatment Failure

2010
Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis.
    Digestive diseases and sciences, 2011, Volume: 56, Issue:12

    Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glycyrrhizic Acid; Hepatitis, Autoimmune; Humans; Injections, Intravenous; Liver Function Tests; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult

2011
A combination of autoimmune hepatitis, sensory-dominant peripheral neuropathy, and primary Sjögren's syndrome in the same patient: a rare association.
    Journal of medicine, 1999, Volume: 30, Issue:1-2

    Topics: Anti-Infective Agents; Diagnosis, Differential; Female; Glycyrrhizic Acid; Hepatitis, Autoimmune; Humans; Liver; Middle Aged; Neurons, Afferent; Peripheral Nervous System Diseases; Salivary Glands; Sjogren's Syndrome; Sural Nerve

1999